Stay updated on market trends for NERV. Roche (OTC: RHHBY) announced that the European Commission has granted marketing authorization to the subcutaneous formulation of relapsing multiple ...
Hosted on MSN1mon
Minerva Neurosciences Stock Hits 52-Week Low at $2.03M inerva Neurosciences Inc. (NASDAQ:NERV) stock has reached a new 52-week low, trading at $2.03, as investors show concern over the company's future prospects. With a market capitalization of just ...
Minerva Neurosciences stock opened at $1.57 on Monday. The stock has a market capitalization of $10.98 million, a P/E ratio of -3.57 and a beta of 0.10. Minerva Neurosciences has a 52 week low of ...
Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...
NERV opened at $1.97 on Friday. Minerva Neurosciences has a one year low of $1.90 and a one year high of $9.84. The business has a 50 day simple moving average of $2.22 and a two-hundred day ...
Japanese disaster alert app NERV says Twitter/X limited its posts just hours after Japan was shaken by an earthquake, severely restricting its ability to share important updates about the ...
Hosted on MSN1mon
Minerva Neurosciences stock hits 52-week low at $2.02Minerva Neurosciences Inc. (NASDAQ:NERV) stock has reached a new 52-week low, trading at $2.02, signaling a period of significant bearish sentiment among investors. According to InvestingPro data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results